Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited
- Autores
- Pérez Lloret, Santiago
- Año de publicación
- 2013
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión enviada
- Descripción
- Fil: Pérez Lloret, Santiago. Hospital Universitario de Toulouse. Departamento de Farmacología Clínica; Francia
Fil: Pérez Lloret, Santiago. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Laboratorio de Farmacología Clínica y Epidemiología; Argentina
Abstract: pomorphine is the oldest dopaminergic agent and was initially known for its emetic properties. Although Weill suggested using it to treat Parkinson’s disease (PD) in 1884, evidence about its antiparkinsonian efficacy was provided initially by Schwab and colleagues in 1951 and then by Cotzias and co-workers in 1970. Subcutaneous injection of the drug displayed potent but short-live antiparkinsonian effects usually at the expense of vomiting and postural hypotension. These limitations coupled with the advent of orally-active dopamine receptor agonists led to a waning in the interest in the drug... - Fuente
- Preprint del documento publicado en European Journal of Neurology, 2013
- Materia
-
APOMORFINA
TRATAMIENTO
ENFERMEDAD DE PARKINSON
ENFERMEDADES NEUROGENERATIVAS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/4.0/
- Repositorio
- Institución
- Pontificia Universidad Católica Argentina
- OAI Identificador
- oai:ucacris:123456789/1635
Ver los metadatos del registro completo
id |
RIUCA_8edeb5cf4a360a9c7593f002136a983f |
---|---|
oai_identifier_str |
oai:ucacris:123456789/1635 |
network_acronym_str |
RIUCA |
repository_id_str |
2585 |
network_name_str |
Repositorio Institucional (UCA) |
spelling |
Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisitedPérez Lloret, SantiagoAPOMORFINATRATAMIENTOENFERMEDAD DE PARKINSONENFERMEDADES NEUROGENERATIVASFil: Pérez Lloret, Santiago. Hospital Universitario de Toulouse. Departamento de Farmacología Clínica; FranciaFil: Pérez Lloret, Santiago. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Laboratorio de Farmacología Clínica y Epidemiología; ArgentinaAbstract: pomorphine is the oldest dopaminergic agent and was initially known for its emetic properties. Although Weill suggested using it to treat Parkinson’s disease (PD) in 1884, evidence about its antiparkinsonian efficacy was provided initially by Schwab and colleagues in 1951 and then by Cotzias and co-workers in 1970. Subcutaneous injection of the drug displayed potent but short-live antiparkinsonian effects usually at the expense of vomiting and postural hypotension. These limitations coupled with the advent of orally-active dopamine receptor agonists led to a waning in the interest in the drug...2013info:eu-repo/semantics/articleinfo:eu-repo/semantics/submittedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttps://repositorio.uca.edu.ar/handle/123456789/16351468-1331 (online)1351-5101 (impreso)10.1111/ene.12113Pérez Lloret, S. Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited [en línea]. Preprint del documento publicado en European Journal of Neurology. 2013. doi:10.1111/ene.12113. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/1635Preprint del documento publicado en European Journal of Neurology, 2013reponame:Repositorio Institucional (UCA)instname:Pontificia Universidad Católica Argentinaengenginfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/2025-07-03T10:55:21Zoai:ucacris:123456789/1635instacron:UCAInstitucionalhttps://repositorio.uca.edu.ar/Universidad privadaNo correspondehttps://repositorio.uca.edu.ar/oaiclaudia_fernandez@uca.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:25852025-07-03 10:55:21.806Repositorio Institucional (UCA) - Pontificia Universidad Católica Argentinafalse |
dc.title.none.fl_str_mv |
Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited |
title |
Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited |
spellingShingle |
Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited Pérez Lloret, Santiago APOMORFINA TRATAMIENTO ENFERMEDAD DE PARKINSON ENFERMEDADES NEUROGENERATIVAS |
title_short |
Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited |
title_full |
Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited |
title_fullStr |
Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited |
title_full_unstemmed |
Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited |
title_sort |
Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited |
dc.creator.none.fl_str_mv |
Pérez Lloret, Santiago |
author |
Pérez Lloret, Santiago |
author_facet |
Pérez Lloret, Santiago |
author_role |
author |
dc.subject.none.fl_str_mv |
APOMORFINA TRATAMIENTO ENFERMEDAD DE PARKINSON ENFERMEDADES NEUROGENERATIVAS |
topic |
APOMORFINA TRATAMIENTO ENFERMEDAD DE PARKINSON ENFERMEDADES NEUROGENERATIVAS |
dc.description.none.fl_txt_mv |
Fil: Pérez Lloret, Santiago. Hospital Universitario de Toulouse. Departamento de Farmacología Clínica; Francia Fil: Pérez Lloret, Santiago. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Laboratorio de Farmacología Clínica y Epidemiología; Argentina Abstract: pomorphine is the oldest dopaminergic agent and was initially known for its emetic properties. Although Weill suggested using it to treat Parkinson’s disease (PD) in 1884, evidence about its antiparkinsonian efficacy was provided initially by Schwab and colleagues in 1951 and then by Cotzias and co-workers in 1970. Subcutaneous injection of the drug displayed potent but short-live antiparkinsonian effects usually at the expense of vomiting and postural hypotension. These limitations coupled with the advent of orally-active dopamine receptor agonists led to a waning in the interest in the drug... |
description |
Fil: Pérez Lloret, Santiago. Hospital Universitario de Toulouse. Departamento de Farmacología Clínica; Francia |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/submittedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
submittedVersion |
dc.identifier.none.fl_str_mv |
https://repositorio.uca.edu.ar/handle/123456789/1635 1468-1331 (online) 1351-5101 (impreso) 10.1111/ene.12113 Pérez Lloret, S. Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited [en línea]. Preprint del documento publicado en European Journal of Neurology. 2013. doi:10.1111/ene.12113. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/1635 |
url |
https://repositorio.uca.edu.ar/handle/123456789/1635 |
identifier_str_mv |
1468-1331 (online) 1351-5101 (impreso) 10.1111/ene.12113 Pérez Lloret, S. Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease : an old drug revisited [en línea]. Preprint del documento publicado en European Journal of Neurology. 2013. doi:10.1111/ene.12113. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/1635 |
dc.language.none.fl_str_mv |
eng eng |
language |
eng |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/4.0/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/4.0/ |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
Preprint del documento publicado en European Journal of Neurology, 2013 reponame:Repositorio Institucional (UCA) instname:Pontificia Universidad Católica Argentina |
reponame_str |
Repositorio Institucional (UCA) |
collection |
Repositorio Institucional (UCA) |
instname_str |
Pontificia Universidad Católica Argentina |
repository.name.fl_str_mv |
Repositorio Institucional (UCA) - Pontificia Universidad Católica Argentina |
repository.mail.fl_str_mv |
claudia_fernandez@uca.edu.ar |
_version_ |
1836638330579582976 |
score |
13.13397 |